[시장보고서]임상의사결정지원시스템(CDSS) 시장 보고서 : 구성요소별, 제품별, 유형별, 제공 모드별, 모델별, 용도별, 지역별(2025-2033년)

임상의사결정지원시스템(CDSS) 시장 보고서 : 구성요소별, 제품별, 유형별, 제공 모드별, 모델별, 용도별, 지역별(2025-2033년)

Clinical Decision Support Systems Market Report by Component, Product, Type, Delivery Mode, Model, Application, and Region 2025-2033

상품코드 : 1635882

리서치사 : IMARC

발행일 : 2025년 01월

페이지 정보 : 영문 125 Pages

라이선스 & 가격 (부가세 별도)

US $ 2,999

￦ 4,466,000

PDF & Excel (Single User License)

PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트 등의 Copy&Paste도 불가능합니다.

US $ 3,999

￦ 5,955,000

PDF & Excel (5 User License)

PDF & Excel 보고서를 동일 기업의 5명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy&Paste가 불가능합니다. 인쇄는 5부까지 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,999

￦ 7,445,000

PDF & Excel (Corporate License)

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계 임상의사결정지원시스템(CDSS) 시장 규모는 2024년 17억 달러에 달했습니다. 향후 IMARC Group은 2033년에는 31억 달러에 달할 것으로 예상하며, 2025-2033년 CAGR은 6.39%로 예측하고 있습니다. 전자건강기록(EHR)의 보급, 만성질환의 증가, 첨단 인공지능(AI)과 머신러닝(ML) 기술의 통합 발전, 지원적인 규제 프레임워크의 도입, 맞춤형 의료에 대한 관심 증가 등으로 인해 시장이 빠르게 성장하고 있습니다.

임상의사결정지원시스템(CDSS)은 전자 의료 기록(EHR) 기록 시스템 내의 데이터를 분석하기 위해 설계된 컴퓨터 기반의 특수 정보 애플리케이션을 말합니다. CDSS는 클라우드 스토리지와 같은 다양한 하드웨어 및 소프트웨어 기반 솔루션을 채택하여 접근 가능한 방대한 양의 임상 및 관리 데이터를 관리 및 저장하는 데 도움을 줍니다. CDSS는 대상 임상 및 건강 관련 정보를 통해 복잡한 의료 의사결정을 내리고, 워크플로우를 간소화하며, 투약 오류의 위험을 억제하고, 오진을 줄이고, 다양한 관리 업무 수행을 지원함으로써 의료 서비스 제공을 강화합니다. 이와는 별도로 의료 행위를 관리하고 신뢰할 수 있는 정보와 관찰을 제공하여 전반적인 업무 효율성을 최적화합니다. 그 결과, CDSS는 병원과 클리닉에서 사용되어 약물 알레르기 경고를 제공하고 환자에게 더 나은 치료를 제공하여 더 나은 임상 결과를 보장합니다.

여러 만성질환을 치료하기 위한 CDSS 솔루션을 포함하여 특수 알고리즘, 대화형 인터페이스, 서비스 지향 아키텍처를 갖춘 다양한 고급 시스템에 대한 수요가 증가함에 따라 시장 성장의 주요 원동력이 되고 있습니다. 이에 따라 인위적인 개입으로 인한 투약 오류 사례가 급증하면서 더 나은 임상적 판단을 내리기 위해 헬스케어 분야에서 CDSS의 채택이 확대되고 있으며, 이 또한 성장을 촉진하는 요인으로 작용하고 있습니다. 또한, 각국 정부가 병원 내 의료 정보통신기술(HICT)의 도입을 촉진하기 위해 적극적인 노력을 기울이고 있는 것도 시장 성장을 촉진하고 있습니다. 이러한 제품은 의료진에게 신뢰할 수 있는 데이터를 제공함으로써 저렴한 비용으로 환자에게 양질의 의료 서비스를 제공하는 데 도움이 됩니다. 또한, 인공지능(AI), 머신러닝(ML), CPOE(Computerized Provider Order Entry), 통계적 패턴 인식 솔루션을 대규모로 통합하고 정보 추출을 위한 데이터 측정을 분석하는 것이 시장 성장을 촉진하고 있습니다. 이러한 기술은 데스크톱, 태블릿, 생체인식 모니터링 시스템, 웨어러블 기기 등 다양한 소비자 전자기기를 통해 추가적으로 관리할 수 있으며, 이는 시장 성장을 촉진하고 있습니다. 이와는 별도로, 의료 인프라의 대폭적인 강화, CDSS의 가용성과 유익한 특성에 대한 소비자의 인식 증가, 첨단 CDSS 솔루션을 설계하기 위한 주요 기업 간의 지속적인 인수합병(M&A)은 시장에 대한 밝은 전망을 만들어내고 있습니다.

본 보고서에서 다루는 주요 질문

세계 임상 의사결정지원시스템(CDSS) 시장은 지금까지 어떻게 성장해 왔을까?
세계 임상 의사결정지원시스템(CDSS) 시장의 시장 촉진요인, 저해요인, 기회요인은 무엇인가?
각 촉진요인, 억제요인, 기회가 세계 임상의사결정지원시스템(CDSS) 시장에 미치는 영향은 무엇인가?
주요 지역 시장은?
임상 의사결정지원시스템(CDSS) 시장에서 가장 매력적인 국가는?
구성요소별 시장 분석은 어떻게 되는가?
임상의사결정지원시스템(CDSS) 시장에서 가장 매력적인 구성요소는?
제품별 시장 분석은?
임상 의사결정지원시스템(CDSS) 시장에서 가장 매력적인 제품은?
유형별 시장 분석은?
임상의사결정지원시스템(CDSS) 시장에서 가장 매력적인 유형은?
제공 모드에 따른 시장 분석은?
임상의사결정지원시스템(CDSS) 시장에서 가장 매력적인 제공 방식은?
모델별 시장 분석은?
임상의사결정지원시스템(CDSS) 시장에서 가장 매력적인 모델은?
용도별 시장 분석은?
임상의사결정지원시스템(CDSS) 시장에서 가장 매력적인 애플리케이션은?
시장의 경쟁 구조는?
세계 임상의사결정지원시스템(CDSS) 시장의 주요 플레이어/기업은?

시장 구조
주요 기업
주요 기업 개요
- Athenahealth Inc.
- Change Healthcare(UnitedHealth Group Incorporated)
- Epic Systems Corporation
- General Electric Company
- International Business Machines Corporation
- Koninklijke Philips N.V.
- NextGen Healthcare Inc.
- Oracle Corporation
- Siemens Healthineers AG(Siemens AG)
- Wolters Kluwer N.V.
- Zynx Health Incorporated(Hearst Business Media Corporation)

ksm

영문 목차

영문목차

The global clinical decision support systems (CDSS) market size reached USD 1.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.1 Billion by 2033, exhibiting a CAGR of 6.39% during 2025-2033. The market is experiencing rapid growth, due to the widespread adoption of electronic health records (EHRs), rising prevalence of chronic diseases, growing integration of advanced artificial intelligence (AI) and machine learning (ML) technologies, imposition of supportive regulatory frameworks, and the heightened focus on personalized medicine.

The clinical decision support system (CDSS) refers to a specialized information computer-based application designed to analyze data within electronic health record (EHR) record systems. It provides reminders to clinicians, physicians, and staff to suggest better clinical treatments for effective patient care. It employs various hardware and software-based solutions, such as cloud storage, which helps manage and store an excessive amount of accessible clinical and administrative data. CDSS assists in enhancing healthcare delivery by making complex medical decisions with targeted clinical and health-related information, streamlines the workflow, inhibits the risk of medication errors, reduces misdiagnoses, and helps in executing diverse administrative operations. Apart from this, it manages medical practices, provides reliable information and observations, and optimizes overall operational efficiency. As a result, CDSS is used by hospitals and clinics to provide drug allergy alerts and ensure better clinical outcomes by providing exceptional care to patients.

The increasing need for various advanced systems with specialized algorithms, interactive interfaces, and service-oriented architectures, including CDSS solutions to treat several chronic disorders, is primarily driving the market toward growth. In line with this, the escalating instances of medication errors due to human intervention have intensified the widespread adoption of CDSS in the healthcare sector to make better clinical decisions, which is acting as another growth-inducing factor. Additionally, favorable initiatives undertaken by governments of various countries to promote the uptake of health information and communication technology (HICT) in hospital settings are favoring the market growth. Such products help provide high-quality care to patients at lower expenditure by furnishing health workers with reliable data. Moreover, the large-scale integration of artificial intelligence (AI), machine learning (ML), computerized provider order entry (CPOE), and statistical pattern recognition solutions to analyze data measurements for extracting information is propelling the market growth. These technologies can be further administered through multiple consumer electronic devices, such as desktops, tablets, biometric monitoring systems, and wearable devices, which is impelling the market growth. Apart from this, significant enhancements in the healthcare infrastructure, growing consumer awareness regarding its availability and beneficial properties, and ongoing mergers and acquisitions (M&A) amongst key players to engineer advanced CDSS solutions are creating a positive outlook for the market.

Key Market Segmentation:

Component Insights:

Hardware
Software
Services

Product Insights:

Integrated CDSS
Standalone CDSS

Type Insights:

Therapeutic
Diagnostic
The report has also provided a detailed breakup and analysis of the clinical decision support systems (CDSS) market based on the type. This includes therapeutic and diagnostic. According to the report, therapeutic represented the largest segment.

Delivery Mode Insights:

On Premise
Cloud Based

Model Insights:

Knowledge Based
Non-Knowledge Based
The report has also provided a detailed breakup and analysis of the clinical decision support systems (CDSS) market based on the model. This includes knowledge and non-knowledge based. According to the report, knowledge based represented the largest segment.

Application Insights:

Drug Allergy Alerts
Clinical Guidelines
Drug-Drug Interactions
Clinical Reminders
Others

Regional Insights:

North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for clinical decision support systems. Some of the factors driving the North America clinical decision support system market included the increasing demand for service-oriented intelligent healthcare decision-making software and the rising instances of medical errors.
Competitive Landscape
The report has also provided a comprehensive analysis of the competitive landscape in the global clinical decision support system market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Athenahealth Inc., Change Healthcare (United Health Group Incorporated), Epic Systems Corporation, General Electric Company, International Business Machines Corporation, Koninklijke Philips N.V., NextGen Healthcare Inc., Oracle Corporation, Siemens Healthineers AG (Siemens AG), Wolters Kluwer N.V., Zynx Health Incorporated (Hearst Business Media Corporation), etc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

How has the global clinical decision support systems (CDSS) market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global clinical decision support systems (CDSS) market?
What is the impact of each driver, restraint, and opportunity on the global clinical decision support systems (CDSS) market?
What are the key regional markets?
Which countries represent the most attractive clinical decision support systems (CDSS) market?
What is the breakup of the market based on the component?
Which is the most attractive component in the clinical decision support systems (CDSS) market?
What is the breakup of the market based on the product?
Which is the most attractive product in the clinical decision support systems (CDSS) market?
What is the breakup of the market based on the type?
Which is the most attractive type in the clinical decision support systems (CDSS) market?
What is the breakup of the market based on the delivery mode?
Which is the most attractive delivery mode in the clinical decision support systems (CDSS) market?
What is the breakup of the market based on the model?
Which is the most attractive model in the clinical decision support systems (CDSS) market?
What is the breakup of the market based on the application?
Which is the most attractive application in the clinical decision support systems (CDSS) market?
What is the competitive structure of the market?
Who are the key players/companies in the global clinical decision support systems (CDSS) market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Clinical Decision Support Systems (CDSS) Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Component

6.1 Hardware
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Software
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Services
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Product

7.1 Integrated CDSS
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Standalone CDSS
- 7.2.1 Market Trends
- 7.2.2 Market Forecast

8 Market Breakup by Type

8.1 Therapeutic
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Diagnostic
- 8.2.1 Market Trends
- 8.2.2 Market Forecast

9 Market Breakup by Delivery Mode

9.1 On Premise
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Cloud Based
- 9.2.1 Market Trends
- 9.2.2 Market Forecast

10 Market Breakup by Model

10.1 Knowledge Based
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
10.2 Non-Knowledge Based
- 10.2.1 Market Trends
- 10.2.2 Market Forecast

11 Market Breakup by Application

11.1 Drug Allergy Alerts
- 11.1.1 Market Trends
- 11.1.2 Market Forecast
11.2 Clinical Guidelines
- 11.2.1 Market Trends
- 11.2.2 Market Forecast
11.3 Drug-Drug Interactions
- 11.3.1 Market Trends
- 11.3.2 Market Forecast
11.4 Clinical Reminders
- 11.4.1 Market Trends
- 11.4.2 Market Forecast
11.5 Others
- 11.5.1 Market Trends
- 11.5.2 Market Forecast

12 Market Breakup by Region

12.1 North America
- 12.1.1 United States
  - 12.1.1.1 Market Trends
  - 12.1.1.2 Market Forecast
- 12.1.2 Canada
  - 12.1.2.1 Market Trends
  - 12.1.2.2 Market Forecast
12.2 Asia-Pacific
- 12.2.1 China
  - 12.2.1.1 Market Trends
  - 12.2.1.2 Market Forecast
- 12.2.2 Japan
  - 12.2.2.1 Market Trends
  - 12.2.2.2 Market Forecast
- 12.2.3 India
  - 12.2.3.1 Market Trends
  - 12.2.3.2 Market Forecast
- 12.2.4 South Korea
  - 12.2.4.1 Market Trends
  - 12.2.4.2 Market Forecast
- 12.2.5 Australia
  - 12.2.5.1 Market Trends
  - 12.2.5.2 Market Forecast
- 12.2.6 Indonesia
  - 12.2.6.1 Market Trends
  - 12.2.6.2 Market Forecast
- 12.2.7 Others
  - 12.2.7.1 Market Trends
  - 12.2.7.2 Market Forecast
12.3 Europe
- 12.3.1 Germany
  - 12.3.1.1 Market Trends
  - 12.3.1.2 Market Forecast
- 12.3.2 France
  - 12.3.2.1 Market Trends
  - 12.3.2.2 Market Forecast
- 12.3.3 United Kingdom
  - 12.3.3.1 Market Trends
  - 12.3.3.2 Market Forecast
- 12.3.4 Italy
  - 12.3.4.1 Market Trends
  - 12.3.4.2 Market Forecast
- 12.3.5 Spain
  - 12.3.5.1 Market Trends
  - 12.3.5.2 Market Forecast
- 12.3.6 Russia
  - 12.3.6.1 Market Trends
  - 12.3.6.2 Market Forecast
- 12.3.7 Others
  - 12.3.7.1 Market Trends
  - 12.3.7.2 Market Forecast
12.4 Latin America
- 12.4.1 Brazil
  - 12.4.1.1 Market Trends
  - 12.4.1.2 Market Forecast
- 12.4.2 Mexico
  - 12.4.2.1 Market Trends
  - 12.4.2.2 Market Forecast
- 12.4.3 Others
  - 12.4.3.1 Market Trends
  - 12.4.3.2 Market Forecast
12.5 Middle East and Africa
- 12.5.1 Market Trends
- 12.5.2 Market Breakup by Country
- 12.5.3 Market Forecast

13 Drivers, Restraints, and Opportunities

13.1 Overview
13.2 Drivers
13.3 Restraints
13.4 Opportunities

14 Value Chain Analysis

15 Porters Five Forces Analysis

15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Competition
15.5 Threat of New Entrants
15.6 Threat of Substitutes

16 Price Analysis

17 Competitive Landscape

17.1 Market Structure
17.2 Key Players
17.3 Profiles of Key Players
- 17.3.1 Athenahealth Inc.
  - 17.3.1.1 Company Overview
  - 17.3.1.2 Product Portfolio
- 17.3.2 Change Healthcare (UnitedHealth Group Incorporated)
  - 17.3.2.1 Company Overview
  - 17.3.2.2 Product Portfolio
  - 17.3.2.3 Financials
- 17.3.3 Epic Systems Corporation
  - 17.3.3.1 Company Overview
  - 17.3.3.2 Product Portfolio
  - 17.3.3.3 SWOT Analysis
- 17.3.4 General Electric Company
  - 17.3.4.1 Company Overview
  - 17.3.4.2 Product Portfolio
  - 17.3.4.3 Financials
  - 17.3.4.4 SWOT Analysis
- 17.3.5 International Business Machines Corporation
  - 17.3.5.1 Company Overview
  - 17.3.5.2 Product Portfolio
  - 17.3.5.3 Financials
  - 17.3.5.4 SWOT Analysis
- 17.3.6 Koninklijke Philips N.V.
  - 17.3.6.1 Company Overview
  - 17.3.6.2 Product Portfolio
  - 17.3.6.3 Financials
  - 17.3.6.4 SWOT Analysis
- 17.3.7 NextGen Healthcare Inc.
  - 17.3.7.1 Company Overview
  - 17.3.7.2 Product Portfolio
  - 17.3.7.3 Financials
  - 17.3.7.4 SWOT Analysis
- 17.3.8 Oracle Corporation
  - 17.3.8.1 Company Overview
  - 17.3.8.2 Product Portfolio
  - 17.3.8.3 Financials
  - 17.3.8.4 SWOT Analysis
- 17.3.9 Siemens Healthineers AG (Siemens AG)
  - 17.3.9.1 Company Overview
  - 17.3.9.2 Product Portfolio
  - 17.3.9.3 Financials
  - 17.3.9.4 SWOT Analysis
- 17.3.10 Wolters Kluwer N.V.
  - 17.3.10.1 Company Overview
  - 17.3.10.2 Product Portfolio
  - 17.3.10.3 Financials
  - 17.3.10.4 SWOT Analysis
- 17.3.11 Zynx Health Incorporated (Hearst Business Media Corporation)
  - 17.3.11.1 Company Overview
  - 17.3.11.2 Product Portfolio

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report

한글목차

본 보고서에서 다루는 주요 질문

목차

제1장 서문

제2장 조사 범위와 조사 방법

제3장 주요 요약

제4장 소개

제5장 세계 임상의사결정지원시스템(CDSS) 시장

제6장 시장 내역 : 구성요소별

제7장 시장 내역 : 제품별

제8장 시장 내역 : 유형별

제9장 시장 내역 : 제공 모드별

제10장 시장 내역 : 모델별

제11장 시장 내역 : 용도별

제12장 시장 내역 : 지역별

제13장 촉진요인, 억제요인, 기회

제14장 밸류체인 분석

제15장 Porter's Five Forces 분석

제16장 가격 분석

제17장 경쟁 구도